'Supporting those receiving immunotherapy by supporting those delivering it'
Dr Anna Olsson-Brown | IOCN Founder and CEO
"Our mission is to build an Immuno-Oncology (IO) community to improve patient care.
Immunotherapy has revolutionised cancer care and is increasingly used to treat cancer in the curative and palliative setting. Despite advances in Immuno-oncology treatments many challenges remain, including the immune-mediated side effects from treatment that hinder its use.
We support all healthcare professionals involved in caring for patients receiving immunotherapy to help address these challenges."